 | • レポートコード：MRC2-11QY11117 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は出血性疾患のグローバル市場について調査・分析したレポートです。種類別（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他）市場規模、用途別（血友病A、血友病B、フォンウィルブランド病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別出血性疾患の競争状況、市場シェア ・世界の出血性疾患市場：種類別市場規模 2015年-2020年（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他） ・世界の出血性疾患市場：種類別市場規模予測 2021年-2026年（血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、デスモプレシン、抗線溶薬、フィブリンシーラント、その他） ・世界の出血性疾患市場：用途別市場規模 2015年-2020年（血友病A、血友病B、フォンウィルブランド病、その他） ・世界の出血性疾患市場：用途別市場規模予測 2021年-2026年（血友病A、血友病B、フォンウィルブランド病、その他） ・北米の出血性疾患市場分析：米国、カナダ ・ヨーロッパの出血性疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの出血性疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の出血性疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの出血性疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novo Nordisk、Bayer、Baxter International、Alnylam Pharmaceuticals、Pfizer、Xenetic Biosciences、Bristol-Myers Squibb Company、Sanofi、Janssen Global Services、Bioverativ、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
Market Analysis and Insights: Global Bleeding Disorders Market
The global Bleeding Disorders market size is projected to reach US$ 11560 million by 2026, from US$ 10810 million in 2020, at a CAGR of 6.4%% during 2021-2026.
Global Bleeding Disorders Scope and Market Size
Bleeding Disorders market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bleeding Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Market segment by Type, the product can be split into
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Market segment by Application, split into
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bleeding Disorders Revenue
1.4 Market by Type
1.4.1 Global Bleeding Disorders Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Plasma-derived Coagulation Factor Concentrates
1.4.3 Recombinant Coagulation Factor Concentrates
1.4.4 Desmopressin
1.4.5 Antifibrinolytics
1.4.6 Fibrin Sealants
1.4.7 Others
1.5 Market by Application
1.5.1 Global Bleeding Disorders Market Share by Application: 2020 VS 2026
1.5.2 Hemophilia A
1.5.3 Hemophilia B
1.5.4 Von Willebrand Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bleeding Disorders Market Perspective (2015-2026)
2.2 Global Bleeding Disorders Growth Trends by Regions
2.2.1 Bleeding Disorders Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bleeding Disorders Historic Market Share by Regions (2015-2020)
2.2.3 Bleeding Disorders Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bleeding Disorders Market Growth Strategy
2.3.6 Primary Interviews with Key Bleeding Disorders Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bleeding Disorders Players by Market Size
3.1.1 Global Top Bleeding Disorders Players by Revenue (2015-2020)
3.1.2 Global Bleeding Disorders Revenue Market Share by Players (2015-2020)
3.1.3 Global Bleeding Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bleeding Disorders Market Concentration Ratio
3.2.1 Global Bleeding Disorders Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bleeding Disorders Revenue in 2019
3.3 Bleeding Disorders Key Players Head office and Area Served
3.4 Key Players Bleeding Disorders Product Solution and Service
3.5 Date of Enter into Bleeding Disorders Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bleeding Disorders Historic Market Size by Type (2015-2020)
4.2 Global Bleeding Disorders Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bleeding Disorders Market Size by Application (2015-2020)
5.2 Global Bleeding Disorders Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bleeding Disorders Market Size (2015-2020)
6.2 Bleeding Disorders Key Players in North America (2019-2020)
6.3 North America Bleeding Disorders Market Size by Type (2015-2020)
6.4 North America Bleeding Disorders Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bleeding Disorders Market Size (2015-2020)
7.2 Bleeding Disorders Key Players in Europe (2019-2020)
7.3 Europe Bleeding Disorders Market Size by Type (2015-2020)
7.4 Europe Bleeding Disorders Market Size by Application (2015-2020)
8 China
8.1 China Bleeding Disorders Market Size (2015-2020)
8.2 Bleeding Disorders Key Players in China (2019-2020)
8.3 China Bleeding Disorders Market Size by Type (2015-2020)
8.4 China Bleeding Disorders Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bleeding Disorders Market Size (2015-2020)
9.2 Bleeding Disorders Key Players in Japan (2019-2020)
9.3 Japan Bleeding Disorders Market Size by Type (2015-2020)
9.4 Japan Bleeding Disorders Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bleeding Disorders Market Size (2015-2020)
10.2 Bleeding Disorders Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bleeding Disorders Market Size by Type (2015-2020)
10.4 Southeast Asia Bleeding Disorders Market Size by Application (2015-2020)
11 India
11.1 India Bleeding Disorders Market Size (2015-2020)
11.2 Bleeding Disorders Key Players in India (2019-2020)
11.3 India Bleeding Disorders Market Size by Type (2015-2020)
11.4 India Bleeding Disorders Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bleeding Disorders Market Size (2015-2020)
12.2 Bleeding Disorders Key Players in Central & South America (2019-2020)
12.3 Central & South America Bleeding Disorders Market Size by Type (2015-2020)
12.4 Central & South America Bleeding Disorders Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Details
13.1.2 Novo Nordisk Business Overview
13.1.3 Novo Nordisk Bleeding Disorders Introduction
13.1.4 Novo Nordisk Revenue in Bleeding Disorders Business (2015-2020))
13.1.5 Novo Nordisk Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Bleeding Disorders Introduction
13.2.4 Bayer Revenue in Bleeding Disorders Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Baxter International
13.3.1 Baxter International Company Details
13.3.2 Baxter International Business Overview
13.3.3 Baxter International Bleeding Disorders Introduction
13.3.4 Baxter International Revenue in Bleeding Disorders Business (2015-2020)
13.3.5 Baxter International Recent Development
13.4 Alnylam Pharmaceuticals
13.4.1 Alnylam Pharmaceuticals Company Details
13.4.2 Alnylam Pharmaceuticals Business Overview
13.4.3 Alnylam Pharmaceuticals Bleeding Disorders Introduction
13.4.4 Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2015-2020)
13.4.5 Alnylam Pharmaceuticals Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Bleeding Disorders Introduction
13.5.4 Pfizer Revenue in Bleeding Disorders Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Xenetic Biosciences
13.6.1 Xenetic Biosciences Company Details
13.6.2 Xenetic Biosciences Business Overview
13.6.3 Xenetic Biosciences Bleeding Disorders Introduction
13.6.4 Xenetic Biosciences Revenue in Bleeding Disorders Business (2015-2020)
13.6.5 Xenetic Biosciences Recent Development
13.7 Bristol-Myers Squibb Company
13.7.1 Bristol-Myers Squibb Company Company Details
13.7.2 Bristol-Myers Squibb Company Business Overview
13.7.3 Bristol-Myers Squibb Company Bleeding Disorders Introduction
13.7.4 Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2015-2020)
13.7.5 Bristol-Myers Squibb Company Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview
13.8.3 Sanofi Bleeding Disorders Introduction
13.8.4 Sanofi Revenue in Bleeding Disorders Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Janssen Global Services
13.9.1 Janssen Global Services Company Details
13.9.2 Janssen Global Services Business Overview
13.9.3 Janssen Global Services Bleeding Disorders Introduction
13.9.4 Janssen Global Services Revenue in Bleeding Disorders Business (2015-2020)
13.9.5 Janssen Global Services Recent Development
13.10 Bioverativ
13.10.1 Bioverativ Company Details
13.10.2 Bioverativ Business Overview
13.10.3 Bioverativ Bleeding Disorders Introduction
13.10.4 Bioverativ Revenue in Bleeding Disorders Business (2015-2020)
13.10.5 Bioverativ Recent Development
13.11 Amgen
10.11.1 Amgen Company Details
10.11.2 Amgen Business Overview
10.11.3 Amgen Bleeding Disorders Introduction
10.11.4 Amgen Revenue in Bleeding Disorders Business (2015-2020)
10.11.5 Amgen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bleeding Disorders Key Market Segments
Table 2. Key Players Covered: Ranking by Bleeding Disorders Revenue
Table 3. Ranking of Global Top Bleeding Disorders Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bleeding Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Plasma-derived Coagulation Factor Concentrates
Table 6. Key Players of Recombinant Coagulation Factor Concentrates
Table 7. Key Players of Desmopressin
Table 8. Key Players of Antifibrinolytics
Table 9. Key Players of Fibrin Sealants
Table 10. Key Players of Others
Table 11. Global Bleeding Disorders Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Bleeding Disorders Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Bleeding Disorders Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Bleeding Disorders Market Share by Regions (2015-2020)
Table 15. Global Bleeding Disorders Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Bleeding Disorders Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Bleeding Disorders Market Growth Strategy
Table 21. Main Points Interviewed from Key Bleeding Disorders Players
Table 22. Global Bleeding Disorders Revenue by Players (2015-2020) (Million US$)
Table 23. Global Bleeding Disorders Market Share by Players (2015-2020)
Table 24. Global Top Bleeding Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bleeding Disorders as of 2019)
Table 25. Global Bleeding Disorders by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Bleeding Disorders Product Solution and Service
Table 28. Date of Enter into Bleeding Disorders Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 31. Global Bleeding Disorders Market Size Share by Type (2015-2020)
Table 32. Global Bleeding Disorders Revenue Market Share by Type (2021-2026)
Table 33. Global Bleeding Disorders Market Size Share by Application (2015-2020)
Table 34. Global Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 35. Global Bleeding Disorders Market Size Share by Application (2021-2026)
Table 36. North America Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Bleeding Disorders Market Share (2019-2020)
Table 38. North America Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 39. North America Bleeding Disorders Market Share by Type (2015-2020)
Table 40. North America Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 41. North America Bleeding Disorders Market Share by Application (2015-2020)
Table 42. Europe Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Bleeding Disorders Market Share (2019-2020)
Table 44. Europe Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Bleeding Disorders Market Share by Type (2015-2020)
Table 46. Europe Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Bleeding Disorders Market Share by Application (2015-2020)
Table 48. China Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 49. China Key Players Bleeding Disorders Market Share (2019-2020)
Table 50. China Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 51. China Bleeding Disorders Market Share by Type (2015-2020)
Table 52. China Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 53. China Bleeding Disorders Market Share by Application (2015-2020)
Table 54. Japan Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Bleeding Disorders Market Share (2019-2020)
Table 56. Japan Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Bleeding Disorders Market Share by Type (2015-2020)
Table 58. Japan Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Bleeding Disorders Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Bleeding Disorders Market Share (2019-2020)
Table 62. Southeast Asia Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Bleeding Disorders Market Share by Type (2015-2020)
Table 64. Southeast Asia Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Bleeding Disorders Market Share by Application (2015-2020)
Table 66. India Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 67. India Key Players Bleeding Disorders Market Share (2019-2020)
Table 68. India Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 69. India Bleeding Disorders Market Share by Type (2015-2020)
Table 70. India Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 71. India Bleeding Disorders Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Bleeding Disorders Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Bleeding Disorders Market Share (2019-2020)
Table 74. Central & South America Bleeding Disorders Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Bleeding Disorders Market Share by Type (2015-2020)
Table 76. Central & South America Bleeding Disorders Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Bleeding Disorders Market Share by Application (2015-2020)
Table 78. Novo Nordisk Company Details
Table 79. Novo Nordisk Business Overview
Table 80. Novo Nordisk Product
Table 81. Novo Nordisk Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 82. Novo Nordisk Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Product
Table 86. Bayer Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 87. Bayer Recent Development
Table 88. Baxter International Company Details
Table 89. Baxter International Business Overview
Table 90. Baxter International Product
Table 91. Baxter International Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 92. Baxter International Recent Development
Table 93. Alnylam Pharmaceuticals Company Details
Table 94. Alnylam Pharmaceuticals Business Overview
Table 95. Alnylam Pharmaceuticals Product
Table 96. Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 97. Alnylam Pharmaceuticals Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Product
Table 101. Pfizer Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 102. Pfizer Recent Development
Table 103. Xenetic Biosciences Company Details
Table 104. Xenetic Biosciences Business Overview
Table 105. Xenetic Biosciences Product
Table 106. Xenetic Biosciences Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 107. Xenetic Biosciences Recent Development
Table 108. Bristol-Myers Squibb Company Company Details
Table 109. Bristol-Myers Squibb Company Business Overview
Table 110. Bristol-Myers Squibb Company Product
Table 111. Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 112. Bristol-Myers Squibb Company Recent Development
Table 113. Sanofi Business Overview
Table 114. Sanofi Product
Table 115. Sanofi Company Details
Table 116. Sanofi Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 117. Sanofi Recent Development
Table 118. Janssen Global Services Company Details
Table 119. Janssen Global Services Business Overview
Table 120. Janssen Global Services Product
Table 121. Janssen Global Services Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 122. Janssen Global Services Recent Development
Table 123. Bioverativ Company Details
Table 124. Bioverativ Business Overview
Table 125. Bioverativ Product
Table 126. Bioverativ Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 127. Bioverativ Recent Development
Table 128. Amgen Company Details
Table 129. Amgen Business Overview
Table 130. Amgen Product
Table 131. Amgen Revenue in Bleeding Disorders Business (2015-2020) (Million US$)
Table 132. Amgen Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bleeding Disorders Market Share by Type: 2020 VS 2026
Figure 2. Plasma-derived Coagulation Factor Concentrates Features
Figure 3. Recombinant Coagulation Factor Concentrates Features
Figure 4. Desmopressin Features
Figure 5. Antifibrinolytics Features
Figure 6. Fibrin Sealants Features
Figure 7. Others Features
Figure 8. Global Bleeding Disorders Market Share by Application: 2020 VS 2026
Figure 9. Hemophilia A Case Studies
Figure 10. Hemophilia B Case Studies
Figure 11. Von Willebrand Disease Case Studies
Figure 12. Others Case Studies
Figure 13. Bleeding Disorders Report Years Considered
Figure 14. Global Bleeding Disorders Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Bleeding Disorders Market Share by Regions: 2020 VS 2026
Figure 16. Global Bleeding Disorders Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Bleeding Disorders Market Share by Players in 2019
Figure 19. Global Top Bleeding Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bleeding Disorders as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Bleeding Disorders Revenue in 2019
Figure 21. North America Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Bleeding Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
凝固因子濃縮物の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor Concentrates Market The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor Concentrates Scope and Market Si…- 凝固XI因子の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor XI Scope and Market Size Coagulation Factor XI marke…
- 組換え凝固因子の世界市場（～2026年） Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Market Analysis and Insights: Global Recomb…
- ヒト凝固因子IXの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IX Market The global Human Coagulation Factor IX market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IX Scope and Market Size Human Coa…
- ヒト凝固因子IVの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IV Market The global Human Coagulation Factor IV market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IV Scope and Market Size Human Coa…